Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Working Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 3.162.692.662.943.12

What is the latest Working Capital/Sales ratio of NGL FINECHEM ?

The latest Working Capital/Sales ratio of NGL FINECHEM is 3.16 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20253.16
Mar20242.69
Mar20232.66
Mar20222.94
Mar20213.12

How is Working Capital/Sales of NGL FINECHEM Trending?

Years Working Capital/Sales % Change
Mar2025 3.16
17.47
Mar2024 2.69
1.13
Mar2023 2.66
-9.52
Mar2022 2.94
-5.77
Mar2021 3.12 -

Other Financial Ratios of NGL FINECHEM


Compare Working Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹873.6 Cr 6.2% 5.1% -28.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,626.0 Cr -1% -4.9% -7.6% Stock Analytics
DIVIS LABORATORIES ₹169,758.0 Cr -1.6% -0.4% 9.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹130,021.0 Cr 0.2% 2.8% 12.2% Stock Analytics
CIPLA ₹122,046.0 Cr 1% -0.9% -1% Stock Analytics
DR REDDYS LABORATORIES ₹106,086.0 Cr 0.4% 0.9% -8.9% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

6.2%

5.1%

-28.4%

SENSEX

-0.4%

-0.6%

8.6%


You may also like the below Video Courses